Using advanced imaging to detect bile duct cancer early
Official title: Multispectral imaging of bile duct epithelial morphology for early detection of malignancy
Funded at Beth Israel Deaconess Medical Center · NIH-10944316 · Data updated 2026-11-12
This study is working on a new way to help doctors find bile duct cancer earlier and more accurately during routine check-ups, using a special light technology that makes it easier to spot any early signs of trouble without needing more invasive tests.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $696,892 |
| NIH project number | 1R01CA293050-01 |
| Project ID | NIH-10944316 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for bile duct cancer or those undergoing procedures related to bile duct evaluation.
✕Less likely to help
Patients with no symptoms or known risk factors for bile duct cancer may not benefit from this research.
What this research studies
This research focuses on improving the early detection of bile duct cancer, also known as cholangiocarcinoma, which is often lethal if not caught in time. The team is developing a new diagnostic technology that combines light scattering and diffuse reflectance spectroscopy to identify pre-cancerous and early cancerous changes in the bile duct during routine procedures. By using a specialized fiber optic probe, the goal is to scan the bile duct's internal surface more effectively and quickly, enhancing the accuracy of diagnosis without needing more invasive techniques. This innovative approach aims to provide a reliable method for detecting bile duct malignancies at an earlier stage.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of bile duct cancer, significantly improving patient outcomes.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for cancer detection, indicating potential success for this novel approach.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Perelman, Lev T — Beth Israel Deaconess Medical Center
- Study coordinator: Perelman, Lev T
Related research
Other NIH-funded projects on the same topics.
-
Detecting cancer risk and treatment response in NF1 nerve tumors using cfDNA markers
A doctor-led study will test blood-based DNA markers to detect when NF1-related nerve tumors become malignant and to monitor how well treatment is working.
-
Epigenetic Basis for Controlling Aggressive IDH-Mutant Gliomas
Aims to understand and shape the epigenetic changes in IDH-mutant brain tumors to restrain their growth, which could lead to new, targeted treatment options for patients.
-
US–East Africa center to prevent and detect virus-linked cancers in people with HIV
This program builds a US–East Africa research network to train local investigators and improve prevention, earlier detection, and faster connection to care for virus-related cancers in people with HIV.
-
U.S.–East Africa program to prevent, detect early, and link people with HIV-related cancers to care
This program brings U.S. and East African teams together to help people with HIV by improving prevention, earlier detection, and faster connection to care for cancers linked to the virus.
-
U.S.–East Africa center to prevent and find HIV-related cancers and speed connection to care
This program builds a U.S.–East Africa team to improve prevention, earlier detection, and faster linkage to care for people with HIV at risk for cervical cancer and Kaposi’s sarcoma.
-
Boosting TET Activity to Help Treat AML with Vitamin C
Vitamin C may help people with a type of blood cancer (AML) by boosting a natural anti-cancer pathway, potentially improving outcomes for adults with this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.